Published on 10 Nov 2023 on Insider Monkey via Yahoo Finance
Daré Bioscience, Inc. (NASDAQ:DARE) Q3 2023 Earnings Call Transcript
Daré Bioscience, Inc. (NASDAQ:DARE) Q3 2023 Earnings Call Transcript November 9, 2023
Daré Bioscience, Inc. beats earnings expectations. Reported EPS is $-0.09, expectations were $-0.1.
Operator: Welcome to the conference hosted by Daré Bioscience to Review the Company's Third Quarter Financial Results and to provide a General Business Update. This call is being recorded. My name is Chris and I will be your operator for today. With us today from Daré are Sabrina Martucci Johnson, President and Chief Executive Officer; John Fair, Chief Commercial Officer; and Lisa Walters-Hoffert, Chief Financial Officer. Ms. Johnson, please proceed.